News & Updates
Filter by Specialty:
Methylnaltrexone proves safety in paediatric oncology patients with constipation
24 Feb 2024
Subcutaneous methylnaltrexone is safe to use in children with cancer who have opioid-induced constipation, suggest the results of a study. In addition, this agent stimulates bowel movements in more than a third of paediatric patients.
Methylnaltrexone proves safety in paediatric oncology patients with constipation
24 Feb 2024Abatacept may mitigate rheumatoid arthritis development in at-risk individuals
24 Feb 2024
byJairia Dela Cruz
The use of abatacept in adults at high risk of rheumatoid arthritis helps protect against disease onset, as shown in the phase IIB APIPPRA study.